Transcutaneous Mechanical Nerve Stimulation (TMNS) by Vibration in the Preservation and Restoration of Urinary Continence and Erectile Function and in the Treatment of Erectile Dysfunction and Urinary Incontinence in Conjunction With Nerve Sparing Radical Prostatectomy

Phase 3

Completed

• Conditions: Erectile Dysfunction; Urinary Incontinence
• Interventions: Device: Transcutaneous mechanical nerve stimulation (TMNS); Other: Pelvic floor muscle training

• Registration Number: NCT01067261
• Lead Sponsor: Copenhagen University Hospital at Herlev

Brief Summary

After radical prostatectomy nerve damage in the pelvic floor usually occurs. This causes side effects in the form of incontinence and erectile dysfunction.

It has previously been shown that one can stimulate the nerves of the pelvic floor by means of transcutaneous mechanical nerve stimulation (TMNS) done through vibration. This study will examine the effect of TMNS in the preservation and restoration of urinary continence and erectile function and in the treatment of urinary incontinence and erectile dysfunction in conjunction with radical prostatectomy.

The theory is that by means of TMNS one can stimulate the nerves of the pelvic floor and the penis which may improve their function and there by prevent or minimize the occurrence of incontinence and erectile dysfunction following pelvic surgery. Vibration may also help to eliminate these symptoms once they have occurred. It is possible that TMNS will also directly increase the blood flow in the cavernosal tissue thus aiding in the preservation of this tissue. In case the improved nerve function is not great enough to secure satisfactory erectile function in itself it may still improve the effect of PDE-5-inhibitors.

In pilot studies TMNS has already shown an effect in the treatment of urinary continence.

In this study the patients will be randomized to either TMNS treatment or no TMNS treatment. In both groups the patients will participate in a pelvic floor muscle training program. In the group receiving active treatment this will be supplemented by TMNS treatment. The two groups will be evaluated and compared with regard to erectile function time to continence after surgery.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-02
• Study First Submitted: 2010-02-10
• Study First Submitted QC: 2010-02-10
• Study First Posted: 2010-02-11
• Status Verified: 2012-12
• Primary Completion: 2013-03
• Study Completion: 2013-03
• Last Update Submitted: 2013-05-23
• Last Update Posted: 2013-05-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 68

Inclusion Criteria

• Scheduled to undergo nerve sparing radical prostatectomy
• Continent before surgery
• A minimum score on the IIEF-questionnaire of 18
• Sexually active

Exclusion Criteria

• Treatment with nitrates
• Treatment with α-blockers
• Serious cardiovascular disease
• Severely reduced liver function,
• Retinitis pigmentosa,
• Non-arteritic ischemic optic neuropathy (NAION)
• Previous vascular infarction of the eye

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
TMNS and pelvic floor muscle training	Transcutaneous mechanical nerve stimulation (TMNS)	This group will receive both the normal pelvic floor muscle training and the TMNS vibration therapy following their radical prostatectomy. Treatment with TMNS will start before the surgery and continue 6 weeks after the surgery.
Pelvic floor muscle training only	Pelvic floor muscle training	This group will receive the normal pelvic floor muscle training after prostatectomy only.

Primary Outcome Measures

Name	Time	Method
Erectile function score by a validated symptom questionnaire (IIEF)	At 3 months, 6 months and 1 year
Time to continence after surgery	At 3 months, 6 months and 1 year

Trial Locations

Locations (2)

Department of Urology, Aarhus University Hospital, Skejby; 🇩🇰 Aarhus N, Denmark

Department of Urology, Herlev University Hospital; 🇩🇰 Herlev, Denmark